CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2190-9172
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation ; day:16 ; month:4 ; year:2016 ; pages:1-13
Dermatology and therapy ; (16.4.2016), 1-13

Urheber
Danish, Hasan H.
Beteiligte Personen und Organisationen
Heumann, Thatcher R.
Bradley, Kyle T.
Switchenko, Jeffrey
Esiashvili, Natia
Lechowicz, Mary Jo
Flowers, Christopher R.
Khan, Mohammad K.
SpringerLink (Online service)

DOI
10.1007/s13555-016-0115-8
URN
urn:nbn:de:1111-201604176880
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:52 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Danish, Hasan H.
  • Heumann, Thatcher R.
  • Bradley, Kyle T.
  • Switchenko, Jeffrey
  • Esiashvili, Natia
  • Lechowicz, Mary Jo
  • Flowers, Christopher R.
  • Khan, Mohammad K.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

CD30+ Cutaneous Anaplastic Large-Cell Lymphoma of the Upper Eyelid: A Case Report

CD30+ Cutaneous Anaplastic Large-Cell Lymphoma of the Upper Eyelid: A Case Report

Cutaneous lymphoma : 37 tables

Konferenzschrift | Kongress

Cutaneous lymphoma : 37 tables

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes

Cutaneous Hodgkin’s lymphoma

Cutaneous Hodgkin’s lymphoma

Long term survival, time to next treatment and CD30 expression in patients with advanced CD30+ cutaneous T-cell lymphoma treated with Brentuximab vedotin : a monocentric retrospective analysis of twelve patients

Long term survival, time to next treatment and CD30 expression in patients with advanced CD30+ cutaneous T-cell lymphoma treated with Brentuximab vedotin : a monocentric retrospective analysis of twelve patients

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma

Primary Cutaneous Anaplastic Large-Cell Lymphoma

Primary Cutaneous Anaplastic Large-Cell Lymphoma

Effects of CD30 overexpression on human lymphoid malignancies : siRNA based, lentivirus mediated silencing of CD30 in Hodgkin's lymphoma and lentivirus mediated ectopic overexpression of CD30 in DLBCL

Hochschulschrift

Effects of CD30 overexpression on human lymphoid malignancies : siRNA based, lentivirus mediated silencing of CD30 in Hodgkin's lymphoma and lentivirus mediated ectopic overexpression of CD30 in DLBCL

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Molecular pathogenesis of cutaneous lymphoma–Future directions

Molecular pathogenesis of cutaneous lymphoma–Future directions

Cutaneous T-Cell Lymphoma with Nasal Necrosis

Cutaneous T-Cell Lymphoma with Nasal Necrosis

Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Verbundene Objekte